MMP9 and hepatocellular carcinoma: In hepatocellular carcinoma cells, CTSB was shown to activate the phosphoinositide 3-kinase/Akt pathway, thereby promoting tumor invasion by increasing matrix metallopeptidase 9 expression [33, 34].